Last updated on July 2017

An Intensive QT/QTc Study to Investigate the Effects of Rovalpituzumab Tesirine on Cardiac Ventricular Repolarization in Subjects with Small Cell Lung Cancer SCRX001-007


Brief description of study

An Intensive QT/QTc Study to Investigate the Effects of Rovalpituzumab Tesirine on Cardiac Ventricular Repolarization in Subjects with Small Cell Lung Cancer SCRX001-007

Detailed Study Description

The purpose of this research study is to evaluate the safety profile of rovalpituzumab tesirine on the heart’s electrical function in subjects with SCLC. The study also serves to determine if rovalpituzumab tesirine can be administered safely and if it is an effective treatment for subjects with SCLC

Clinical Study Identifier: TX151313

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.